Centiva Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $101M | Buy |
279,500
+24,100
| +9% | +$8.25M | 0.88% | 21 |
|
|
2026
Q1 | $89.9M | Buy |
255,400
+200,700
| +367% | +$71.5M | 0.66% | 30 |
|
|
2025
Q4 | $17.9M | Buy |
54,700
+24,700
| +82% | +$7.84M | 0.15% | 113 |
|
|
2025
Q3 | $8.47M | Buy |
+30,000
| New | +$8.7M | 0.08% | 170 |
|
|
2025
Q2 | – | Sell |
-7,000
| Closed | -$2.18M | – | 1497 |
|
|
2025
Q1 | $2.18M | Sell |
7,000
-5,500
| -44% | -$1.62M | 0.07% | 163 |
|
|
2024
Q4 | $3.26M | Buy |
12,500
+1,300
| +12% | +$386K | 0.07% | 157 |
|
|
2024
Q3 | $3.61M | Buy |
11,200
+7,200
| +180% | +$2.36M | 0.07% | 233 |
|
|
2024
Q2 | $1.25M | Buy |
4,000
+2,000
| +100% | +$588K | 0.02% | 664 |
|
|
2024
Q1 | $569K | Buy |
2,000
+1,500
| +300% | +$439K | 0.01% | 924 |
|
|
2023
Q4 | $144K | Sell |
500
-34,800
| -99% | -$9.48M | ﹤0.01% | 1519 |
|
|
2023
Q3 | $9.49M | Buy |
35,300
+30,700
| +667% | +$7.66M | 0.21% | 81 |
|
|
2023
Q2 | $1.02M | Buy |
4,600
+3,600
| +360% | +$835K | 0.02% | 564 |
|
|
2023
Q1 | $242K | Sell |
1,000
-1,500
| -60% | -$368K | 0.01% | 1149 |
|
|
2022
Q4 | $657K | Sell |
2,500
-5,100
| -67% | -$1.37M | 0.02% | 689 |
|
|
2022
Q3 | $1.72M | Sell |
7,600
-6,500
| -46% | -$1.58M | 0.03% | 406 |
|
|
2022
Q2 | $3.43M | Sell |
14,100
-11,000
| -44% | -$2.7M | 0.08% | 223 |
|
|
2022
Q1 | $6.07M | Buy |
25,100
+20,100
| +402% | +$4.62M | 0.12% | 122 |
|
|
2021
Q4 | $1.13M | Buy |
+5,000
| New | +$1.06M | 0.02% | 576 |
|
|
2020
Q4 | – | Sell |
-14,400
| Closed | -$3.66M | – | 895 |
|
|
2020
Q3 | $3.66M | Sell |
14,400
-900
| -6% | -$223K | 0.24% | 70 |
|
|
2020
Q2 | $3.61M | Sell |
15,300
-20,600
| -57% | -$4.7M | 0.22% | 63 |
|
|
2020
Q1 | $7.28M | Sell |
35,900
-54,200
| -60% | -$11.8M | 0.33% | 35 |
|
|
2019
Q4 | $21.7M | Buy |
+90,100
| New | +$19.9M | 1.06% | 14 |
|
|
2019
Q2 | – | Sell |
-21,100
| Closed | -$4.01M | – | 426 |
|
|
2019
Q1 | $4.01M | Sell |
21,100
-24,400
| -54% | -$4.66M | 0.27% | 60 |
|
|
2018
Q4 | $8.86M | Buy |
45,500
+23,400
| +106% | +$4.57M | 0.7% | 21 |
|
|
2018
Q3 | $4.58M | Buy |
22,100
+15,400
| +230% | +$3.03M | 0.4% | 37 |
|
|
2018
Q2 | $1.24M | Buy |
+6,700
| New | +$1.19M | 0.26% | 34 |
|
Other funds holding AMGN
Centiva Capital's AMGN Position: Q2 2026 in Review
Centiva Capital increased its Amgen (AMGN) stake by 45% in Q2 2026, buying an estimated $2.83M and bringing the position to 26,442 shares worth $9.58M. The position accounts for 0.08% of the portfolio, ranked #175.
Centiva Capital first reported a position in AMGN in Q4 2018 and has held it in 24 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Centiva Capital held 26,442 shares of Amgen worth $9.58M as of Q2 2026.
- Centiva Capital bought 8,259 Amgen shares in Q2 2026, an estimated $2.83M.
- Amgen made up 0.08% of Centiva Capital's portfolio in Q2 2026, its #175 holding.
- Centiva Capital first reported a position in Amgen in Q4 2018 and has held it in 24 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.